# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-003411
Filing Date
2025-04-09
Accepted
2025-04-09 16:15:45
Documents
19
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14a.htm iXBRL | DEF 14A | 586101
2 |  | formdef14a_03.jpg | GRAPHIC | 105160
3 |  | formdef14a_04.jpg | GRAPHIC | 108061
4 |  | proxy_001.jpg | GRAPHIC | 351287
5 |  | proxy_002.jpg | GRAPHIC | 441994
| Complete submission text file | 0001641172-25-003411.txt |  | 3716519

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | abeo-20241231.xsd | EX-101.SCH | 5447
7 | XBRL CALCULATION FILE | abeo-20241231_cal.xml | EX-101.CAL | 896
8 | XBRL DEFINITION FILE | abeo-20241231_def.xml | EX-101.DEF | 9278
9 | XBRL LABEL FILE | abeo-20241231_lab.xml | EX-101.LAB | 62570
10 | XBRL PRESENTATION FILE | abeo-20241231_pre.xml | EX-101.PRE | 45446
21 | EXTRACTED XBRL INSTANCE DOCUMENT | formdef14a_htm.xml | XML | 65619

Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 25825388
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)